TY - JOUR T1 - What Treatment Outcomes Matter Most? A Q-study of Outcome Priority Profiles Among Youth with Lived Experience of Depression JF - medRxiv DO - 10.1101/2020.10.12.20210468 SP - 2020.10.12.20210468 AU - K. R. Krause AU - J. Edbrooke-Childs AU - H. A. Bear AU - A. Calderón AU - M. Wolpert Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/14/2020.10.12.20210468.abstract N2 - Objective Over the past years, interest in youth perspectives on what constitutes an important outcome in the treatment of depression has been growing, but limited attention has been given to heterogeneity in outcome priorities and minority viewpoints. These are important to consider for person-centered outcome tracking in clinical practice, or when conducting clinical trials targeting specific populations. This study used Q-methodology to identify outcome priority profiles among youth with lived experience of service use for depression.Method A purposive sample of 28 youth (aged 16–21 years) rank-ordered 35 outcomes by importance and completed brief semi-structured interviews eliciting their sorting rationales. By-person principal component analysis was used to identify outcome priority profiles based on all Q-sort configurations. Priority profiles were described and interpreted with reference to the qualitative interview data.Results Four distinct outcome priority profiles were identified: “symptom reduction and enhanced well-being”; “improved coping and self-management”; “better understanding past and present”; and “less interference with daily life”. All four profiles prioritized outcomes related to improved mood and affect over other outcome concepts. Beyond these core outcomes, profiles differed in the level of importance assigned to learning practical coping skills, processing experiences, finding safe ways to articulate emotions, and reduced interference of depression with life and identity.Conclusion As part of a person-centered approach to care delivery, care providers should routinely engage young people in conversation and shared decision-making about the types of change they would like to prioritize and track during treatment, beyond a common core of consensus outcomes.Competing Interest StatementKRK was involved in the development of the ICHOM Standard Outcome Set for child and youth anxiety and depression and received personal fees from ICHOM during the development of the Standard Set. The ICHOM Standard Set is available free of charge and there is no financial conflict of interest. KRK is also a co-investigator in the IN-ROADS initiative which aims to develop a Core Outcome Set (COS) for youth depression trials. The recommendations made by that COS will be freely available and there is no financial conflict of interest. MW is head of the Mental Health Priority Area at the Wellcome Trust, which may be developing core metrics in mental health in the future. JEC, HAB and AC have no conflicts of interest to report.Funding StatementThis study was funded through an IMPACT studentship awarded to Karolin R. Krause by University College London and the Anna Freud National Centre for Children and Families for the completion of a three-year PhD project (2016-2019). This research did not receive a specific grant from any funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics review committee of University College London in March 2018 (UCL REC REF: 10567/002), and performed in accordance with the ethical standards of the committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All participants were above the age of 16 and provided informed written consent. All interview data were anonymized, and names replaced with pseudonyms.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in this manuscript cannot be made publicly available, as study participants did not provide explicit consent for data sharing. ER -